UNITED BREWERIES CO INC
CCUAbout the company
Compañía Cervecerías Unidas S.A., together with its subsidiaries, operates as a diversified beverage company in Chile, Argentina, Bolivia, Colombia, Paraguay, and Uruguay. It operates through three segments: Chile, International Business, and Wine. The company offers wines, soft, isotonic, and sports drinks, nectars, iced tea, pisco, rum, cider, liquors, beers, spirits, cocktails, coolers, and cockail wines; and spring, bottled, mineral, and saborized water.
Investment snapshot
Positive
3
BUY / PASS
Neutral / negative
4 / 9
NEUTRAL / FAIL
Median fair value
$5.64
-47.5% vs price
Models with upside
4 / 17
Positive margin of safety
Strongest signal
7 of 10 pass — Lynch, Pabrai and Oshaughnessy object
Key risk
15 of 16 flag CCU's profitability — Graham, Buffett, Lynch +12 more
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #665 (Top 21.5%) | NEUTRAL | PASS | PASS | FAIL | FAIL | FAIL | FAIL | NEUTRAL | PASS | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| Margin of Safety | N/A | +54.9% | N/A | +4.7% | N/A | N/A | -18.7% | -107.5% | +40.8% | +47.4% | -16.8% | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-29 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-29 Score computed: 2026-11-14 |
Where It Passes
- Cash Flow70% pass✓ 9✗ 3▾
7 of 10 pass — Lynch, Pabrai and Oshaughnessy object
Free Cash Flow Proxy$178.0M✓BuffettPositive and growingFCF Positive and Growing$135.5M✗LynchPositive and growingOperating Cash Flow$289.4M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.21%, ROA=4.42%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)6.9x✓Dreman< 8xP/E or FCF YieldFCF Yield=6.8%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive9/10 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap6.8%✓Ackman>= 4%Price / FCF per Share14.7x✓Ackman<= 25Positive Operating Cash Flow frequency10/10 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$135.5M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+6.81%; #1201/4519 (top 26.6%)✗OshaughnessyTop 10% of eligible cross-section - Valuation models57% pass✓ 4✗ 3▾
Models split on CCU at $10.75 — fair values range $2.59–$11.91
Buffett fair value$11.91✓Buffett+54.9% margin vs $10.75Greenblatt fair value$5.64✓Greenblatt+4.7% margin vs $10.75Munger fair value$4.53✗Munger-18.7% margin vs $10.75Pabrai fair value$2.59✗Pabrai-107.5% margin vs $10.75Akre fair value$9.08✓Akre+40.8% margin vs $10.75Marks fair value$10.21✓Marks+47.4% margin vs $10.75Ackman fair value$4.60✗Ackman-16.8% margin vs $10.75
Where It Falls Short
- Profitability6% pass✓ 11✗ 24▾
15 of 16 flag CCU's profitability — Graham, Buffett, Lynch +12 more
Net income / market capitalization+8.93%; #816/6340 (top 12.9%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)4/11 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)10/11 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)11.3%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)9.0% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$178.0M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR37.4%✓Lynch15-30% (Fast Grower); > 0% to passROE11.6%✗Lynch> 15%EBIT / Enterprise Value16.7%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=16.7%, ROC=12.9%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets4.42%✓PiotroskiROA > 0ROA Change YoY3.46% -> 4.42% (delta: +0.97%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.21%, ROA=4.42%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY46.3% -> 45.2%✗PiotroskiImproved YoYPre-Tax Income / Revenue5.7%✗Dreman>= 8%Net Income / Shareholders' Equity11.6%✗Dreman> 12%Margin of SafetyP/B=1.3x✓PabraiP/B < 1.5 or P/E < 15Return on Equity10.5% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic Value✗Marks>= 20% below intrinsic valuePositive Net Income Frequency10/10 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue9.0%✗Ackman>= 15%Net Income / Shareholders Equity11.6%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend8.1% (2022) -> 9.0% (2024)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 44.1% -> 45.2%, operating margin 8.1% -> 9.0%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets+32.92%; #1275/3702 (top 34.4%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+11.58%; #1572/5226 (top 30.1%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0152; #1172/5884 (top 19.9%)✓AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR37.4% over 3 years✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Debt & Leverage8% pass✓ 3✗ 12▾
11 of 12 flag CCU's debt & leverage — Graham, Buffett, Lynch +8 more
LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest Coverage✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities2.06✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00xDebt Levels✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=2.7x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity✗Ackman<= 1.0Negative debt-to-equity (higher means less debt)✗AsnessTop 30% of eligible cross-section - Valuation15% pass✓ 9✗ 19▾
11 of 13 flag CCU's valuation — Graham, Lynch, Greenblatt +8 more
Price / Book Value per Share1.3x✗Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Net income / market capitalization+8.93%; #816/6340 (top 12.9%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio1.3x✓Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value16.7%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=16.7%, ROC=12.9%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)6.9x✓Dreman< 8xValuation ReasonablenessOE Yield=9.0%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldFCF Yield=6.8%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/B=1.3x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value✗Marks>= 20% below intrinsic valuePrice / FCF per Share14.7x✓Ackman<= 25Price vs. Trailing Low103% of trailing low ($5.22)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+0.7715; #2008/6449 (top 31.1%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share1.76x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change-15.3%✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+1.4692; #1363/5247 (top 26.0%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+6.81%; #1201/4519 (top 26.6%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-14.27%; #3680/6202 (top 59.3%)✗OshaughnessyTop 10% of eligible cross-section - Verdicts23% pass✓ 3✗ 10▾
Split decision: 9 FAIL · 4 NEUTRAL · 3 PASS
Overall verdict✗GrahamFAIL (3/9)✗BuffettFAIL (3/9)✗LynchFAIL (2/7)✗GreenblattRank #665•PiotroskiNEUTRAL (F-Score 6)✓DremanPASS (6/11)✓MungerPASS (2/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (3/5)✗AckmanFAIL (3/9)•TempletonNEUTRAL (5/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (3/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked) - Growth25% pass✓ 5✗ 8▾
6 of 8 flag CCU's growth — Graham, Lynch, Ackman +3 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR37.4%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -3.9% vs Rev: 0.8%✓LynchInventory growth < Revenue growthEPS Growth Direction$0.46 (2015) -> $1.20 (2018)✓DremanPositive over recent yearsEPS CAGR37.4% CAGR over 3 years✓Dreman> 5% annualizedPositive Net Income Frequency10/10 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth0.8%✗Ackman>= 5%Positive EPS Growth Frequency✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 44.1% -> 45.2%, operating margin 8.1% -> 9.0%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR3.3%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR37.4% over 3 years✗Neff7%-20% annualized - Efficiency38% pass✓ 4✗ 7▾
5 of 8 flag CCU's efficiency — Greenblatt, Piotroski, Munger +2 more
Current Ratio2.06✓Graham>= 2.0ROIC (3-5 yr avg)15.3%✓Buffett> 10%ROIC - WACC+5.3%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)12.9%✗Greenblatt> 25%Current Ratio Change YoY2.33 -> 2.06✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.75x -> 0.73x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities2.06✓Dreman> 1.5Return on Invested Capital✗Munger> 15%ROIC (high and growing)FY2022: ROIC=unavailable; FY2023: ROIC=unavailable; FY2024: ROIC=unavailable✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)1/2 years above 12% (latest 19.4%)✗SleepROIC > 12% in a majority of years
Business & financials
Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Retired 0.0% of shares last year, 0.0% over two.
- Buybacks
- —
- Dividends
- $82.3M
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
| FY 2020Sources
|
|---|---|---|---|---|---|
| Market Cap | $2.0Bcurrent | $4.2Best. | $5.4Best. | $5.4Best. | $4.8Best. |
| Revenue | $2.9B↑1% | $2.9B↓8% | $3.2B↑9% | $2.9B↑12% | $2.6B |
| Operating Income | $264.4M↓3% | $271.3M↑6% | $255.6M↓34% | $388.1M↑58% | $246.4M |
| Net Income | $177.7M↑33% | $133.9M↓15% | $158.3M↓38% | $257.3M↑69% | $152.2M |
| EPS (Diluted) | -- | -- | -- | -- | -- |
| Gross Margin | 45.2%↓2% | 46.3%↑5% | 44.1%↓8% | 48.0%↑2% | 47.0% |
| Operating Margin | 9.0%↓3% | 9.4%↑16% | 8.1%↓39% | 13.3%↑41% | 9.4% |
| ROE | 11.6%↑19% | 9.7%↓6% | 10.3%↓38% | 16.8%↑101% | 8.3% |
| Total Debt | -- | -- | -- | $41.3M↓9% | $45.2M |
| Shareholders' Equity | $1.5B↑11% | $1.4B↓10% | $1.5B | $1.5B↓16% | $1.8B |
| Current Ratio | 2.06↓12% | 2.33↑12% | 2.08↑49% | 1.40↓24% | 1.84 |
| Debt / Equity | — | — | — | 0.03↑8% | 0.02 |
| Operating Cash Flow | $289.4M↓13% | $332.4M↑519% | $53.7M↓84% | $344.5M↓13% | $394.8M |
| Free Cash Flow | $135.5M↓29% | $191.8M↑215% | -$166.7M↓215% | $145.3M↓37% | $230.2M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Beer & Liquor
CCU vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COCA COLA COKO | $427.0B | $99.25 | $47.9B | $13.1B | 40.7% | 1.37 | 28.7% | 1.46 | 3/9 | 6/9 | 4/7 | 1/3 | F-Score 7 | 3/11 |
| PEPSICO INCPEP | $198.2B | $145.44 | $93.9B | $8.2B | 40.4% | 2.41 | 12.2% | 0.85 | 4/9 | 6/9 | 3/7 | 1/3 | F-Score 5 | 6/11 |
| Anheuser-Busch InBev SA/NVBUD | $167.0B | $84.81 | $59.3B | $6.8B | 7.8% | 0.84 | 26.0% | 0.72 | 1/9 | 1/9 | 3/7 | 1/3 | F-Score 7 | 2/11 |
| DIAGEO PLCDEO | $56.6B | $101.59 | $28.0B | $2.5B | 22.9% | 2.14 | 15.5% | 1.63 | 1/9 | 4/9 | 2/7 | 1/3 | F-Score 4 | 5/11 |
| Keurig Dr Pepper Inc.KDP | $49.5B | $36.34 | $16.6B | $2.1B | 8.1% | 0.63 | 21.5% | 0.64 | 2/9 | 2/9 | 2/7 | 1/3 | F-Score 6 | 2/11 |
| AMBEV S.A.ABEV | $42.5B | $2.76 | $16.1B | $2.8B | 17.6% | 0.04 | 26.4% | 0.96 | 1/9 | 5/9 | 6/7 | 3/3 | F-Score 6 | 4/11 |
| CONSTELLATION BRANDS, INC.STZ | $24.6B | $145.61 | $9.1B | $1.7B | 20.9% | 1.27 | 29.8% | 1.08 | 1/9 | 2/9 | 2/7 | 1/3 | F-Score 5 | 5/11 |
| BROWN FORMAN CORPBF-B | $14.1B | $30.65 | $3.9B | $715.0M | 17.8% | 0.61 | 25.5% | 3.24 | 5/9 | 6/9 | 2/7 | 1/3 | F-Score 7 | 5/11 |